Teva Pharmaceutical Industries (NYSE:TEVA) recently received FDA acceptance of its supplemental Biologics License Application ...

The healthcare sector is tearing in two amid the stock market’s tariff-induced turmoil. Investors looking for safety from ...

We recently published a list of Top 9 Healthcare Stocks to Buy According to Billionaire David Einhorn. In this article, we ...

Teva Pharmaceutical Industries Limited’s TEVA share price has dipped by 10.66%, which has investors questioning if this is ...

Bearish flow noted in Teva (TEVA) with 36,896 puts trading, or 26x expected. Most active are Apr-25 12.5 puts and May-25 16 calls, with total ...

Teva Pharmaceutical Industries (NYSE:TEVA – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research note issued to investors on Friday.

Teva Pharmaceutical Industries Limited (NYSE:TEVA – Get Free Report) has earned a consensus rating of “Moderate Buy” from the ...

Israel-based Teva Pharmaceuticals industries (NYSE: TEVA) today revealed two important updates reflecting its commitment to ...

EPYSQLI ® (eculizumab-aagh) is now available to patients living with difficult-to-treat rare diseases like paroxysmal nocturnal hemoglobinuria, ...

Explore the impact of proposed Pharma tariffs on global markets as major stocks tumble. Click for my updated look at selected picks in the health industry.

New data from Israel-based generics giant Teva Pharmaceutical Industries (NYSE: TEVA) show favorable patient and healthcare ...

Assess today's live Teva Pharmaceutical Industries Ltd DRC (T1EV34) share price, performance and insights using our live B3: T1EV34 stock exchange data. Analyse the historical data and Teva ...